From: 27/01/2017 to: 27/01/2017 Breast Cancer Screening and Early Detection (ECCO2017 Society Day), Amsterdam, The Netherlands                                        From: 27/01/2017 to: 28/01/2017 Workshop of the European Laryngeal Society: Early Cancer of the Larynx, Leipzig, Germany                                        From: 02/02/2016 to: 03/02/2016 ESMO Preceptorship on Immuno-Oncology 2016, Madrid, Spain                                        From: 1/03/2017 to: 3/03/2017 Innovation in Radio-Oncology Course, Tel Aviv, Israel                                        From: 03/03/2017 to: 06/03/2017 Masterclass in Endoscopy in Gastrointestinal Oncology, Njimegen, The Netherlands                                        From: 24/03/2017 to: 24/03/2017 4th ESO Prostate Cancer Observatory: innovation and care in the next 12 months, London, United Kingdom                                        From: 25/03/2017 to: 30/03/2017 16th ESO-ESMO Masterclass in Clinical Oncology, Nauen OT Groß Behnitz (Berlin area), Germany                                        From: 25/03/2017 to: 30/03/2017 10th ESO-EONS Masterclass in Oncology Nursing, Nauen OT Groß Behnitz (Berlin area), Germany                                        From: 12/04/2017 to: 13/04/2017 9th Clinical Oncology Update - Onkologia 2017, Krakow, Poland                                        From: 26/01/2017 to: 30/01/2017 3rd ESO-ESMO Latin-American Masterclass in Clinical Oncology, San Jose, Costa Rica                                        From: 18/05/2017 to: 19/05/2017 Eurasia Course on Gastrointestinal Malignancies, Moscow, Russian Federation                                        From: 22/05/2017 to: 26/05/2017 3rd ESOP-ESO Advanced Masterclass in Oncology Pharmacy, Lisbon, Portugal                                        From: 10/06/2017 to: 13/06/2017 Leukaemia and Lymphoma, Ascona, Switzerland                                        From: 21/06/2017 to: 23/06/2017 Masterclass in Oncology Basics for Beginners, Cambridge, United Kingdom                                        From: 30/06/2017 to: 05/07/2017 4th ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology, Belgrade, Serbia                                        From: 13/07/2017 to: 18/07/2017 ESMO-ESO Course on Medical Oncology for Medical Students, Valencia, Spain                                        From: 28/08/2017 to: 08/09/2017 ESO-ESSO-ESTRO Multidisciplinary Course in Oncology for Medical Students, Antwerp, Belgium                                        From: 06/10/2017 to: 07/10/2017 Eastern Europe and Balkan Region Refresher Course on Breast Cancer, Krakow, Poland                                        From: 18/10/2017 to: 20/10/2017 4th Masterclass in Clinical Oncology, Tbilisi, Georgia                                        From: 02/11/2017 to: 04/11/2017 ESO-ESMO Advanced Breast Cancer Fourth International Consensus Conference (ABC4), Lisbon, Portugal                                        From: 24/11/2017 to: 25/11/2017 Molecular Diagnostics, Genomics and Epigenetics in Clinical Oncology, Rome, Italy                                        From: 02/12/2017 to: 04/12/2017 ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers, Milan, Italy



In collaboration with

             Media partner:
 

 

            
             
Held under the patronage of
 


And with the support of

    
    
    



Programme Structure


23 October 2014
 
 Evening
 Arrival

21:00 What we want to achieve in this WOF
A. Eggermont

   
24 October 2014
   
9:00
 Introduction
F. Cavalli

SESSION I
Chairperson: PG. Pelicci, IEO Milan

9:15
 Challenges and opportunities for translating basic cancer research into new treatments
P. Workman, The Institute of Cancer Research, London

10:00
 Discussion

10:45
 Coffee break

SESSION II
Chairperson: Richard Schilsky, American Society of Clinical Oncology, USA


 11:15 The new role of immunotherapy in cancer treatment
L. Zitvogel, Gustave Roussy Cancer Campus Grand Paris, Paris

 12:00 Discussion

 13:00 

Lunch

 14:30 Short Presentation

Initiative for providing anti-cancer drugs to Eastern Europe
M. Piccart, Brussels

 14:45 Short Presentation

Global taskforce on radiotherapy for cancer control (GTFRCC)
M. Gospodarowicz, Toronto

SESSION III
Chairperson: A. Eggermont, Gustave Roussy Cancer Campus Grand Paris, Paris


15:30 How to evaluate the utility of cancer treatment
M. Rawlins, NICE, London

 16:15 Discussion

17:00
 Coffee break

 17:30 General discussion

 19:00 Close
   
25 October 2014 
   
SESSION IV
Chairperson: C. Wild, IARC, Lyon

 8:30
 Efficacious and affordable treatments in the developing countries
R. Sankaranarayanan, IARC, Lyon

 10:00 Short Presentation

Update on Global Taskforce on Expanded Access to Cancer Care and Control
M. Gospodarowicz, Toronto

 10:15 Surgery in low and middle income countries
R. Sullivan, UK

 10:30 Coffee break

 10:45 Final discussion 
F. Cavalli and A. Eggermont
   



 Presentations
 
 Most of the speaker's presentation slides are available here
 Please, be aware that the slides are restricted to ClubESO members only.
 We invite you to subscribe (free-of-charge) to ClubESO here





Video


Please, click here to view the video.





Participants

Fifty experts were invited to attend the 2014 meeting and contribute to the discussion. Participants were selected based on the following criteria:

   

 Leading cancer clinicians and researchers who have partially or already participated in the first edition of WOF, with the addition of new experts related to the topic to be discussed.
   

 Leaders who represent important international organizations.
   

Matti Aapro, Clinique de Genolier, Switzerland
Andree Blaukat, Merck Serono, Germany
Christopher Booth, Queen’s University, Canada
Riccardo Braglia, Helsinn, Switerland
Otis Brawley, American Cancer Society, USA
Franco Cavalli, European School of Oncology, Switzerland
Eduardo Cazap, Latin-American & Caribbean Society of Medical Oncology (SLACOM), Argentina
Thomas Cerny, HCARE-KSSG-ONKO, Switzerland
Alberto Costa, European School of Oncology, Italy and Switzerland
Alexander M.M. Eggermont, Gustave Roussy Cancer Campus Grand Paris, France
Nelly Enwerem-Bromson, IAEA, Austria
Mary Gospodarowicz, Princess Margaret Cancer Centre, Canada
Axel Hanauske, Lilly Deutschland GmbH, Germany
Augustin Lage, Center of Molecular Immunology (CIM), Cuba
Jonathan Licht, Northwestern University, USA
Ian Magrath, International Network for Cancer, Belgium
Alex Matter, Experimental Therapeutic Centre & D3, A*STAR, Singapore
Rene Medema, Netherlands Cancer Institute, The Netherlands
Hitoshi Nakagama, National Cancer Center Research Institute, Japan
Douglas Noonan, Università degli Studi dell’Insubria, Italy
Jakob Passweg
, Universitätspital Basel, Switzerland
Pier Giuseppe Pelicci, European Institute of Oncology, Italy
Martine Piccart, Institute Jules Bordet, Belgium
Bob Pinedo, VU Medical Center/Fundashon Prevenshon, The Netherlands/Curacao
Michael Rawlins, UK
Rengaswamy Sankaranarayanan, International Agency for Research on Cancer (IARC), France
Luiz Santini, INCA – Brazilian National Cancer Institute, Brazil
Richard Schilsky, American Society of Clinical Oncology, USA
Steve Shak, Genomic Health, USA
Andreas Ullrich, World Health Organization, Switzerland
Chris Wild, International Agency for Research of Cancer (IARC), France
Paul Workman, The Institute of Cancer Research, UK
Laurence Zitvogel, Gustav Roussy Cancer Campus Grand Paris, France
Walter Zoss, Network of National  Cancer Institutes of the Union of the South American Nations, Brazil

ESO Observers
Andrea Decensi, E. O. Espedali Galliera, Italy
Olivia Pagani, Oncology Institute of Southern Switzerland, Switzerland
Anna Wagstaff, Cancer World Magazine, UK



Media Partners


WOF 2014 was again organized in conjunction with Cancer World  (www.cancerworld.org), which explores the world of European cancer care from the perspective of the clinician, the researcher, the administrator and the patient. The magazine gives a voice to health professionals in all fields and at all levels, and offers a platform to those who are most affected by cancer - the people with the disease.

The exclusive scientific media partner for WOF 2014 was again The Lancet. We are very proud of this partnership since The Lancet is by far the most authoritative scientific journal in its field printed in Europe and will provide greater visibility to WOF. In 2012 The Lancet published, on at least two occasions, editorials and commentaries about WOF while the three keynote lectures were published as complete papers in the December 16, 2013 online issue and will be published in print in early 2014.



Background


On the occasion of the 30th anniversary of ESO, the first edition of the World Oncology Forum was organised in Lugano at the end October 2012 (link a WOF 2012).  100 invited experts, including almost 20 scientific journalists from the lay as well as from the scientific press, discussed during two days the question: “Are we winning the war against cancer?” 
.


 


The meeting was organised with the scientific collaboration of The Lancet, whose Editor-in-Chief R. Horton led the final discussion which resulted in the formulation of the Appeal “Stop Cancer Now!”. This Appeal was then published as a full page advertisement on 4th February 2013 (World Cancer Day) in the corresponding languages of five leading global newspapers: the International Herald Tribune, Le Monde, El Pais, Neuer Zurcher Zeitung, La Repubblica. WOF 2014 and the Appeal also appeared as the subject of a feature piece in Cancer World.



      The Stop Cancer Now! appeal is available as a pdf in:

English
French

German
Italian
Spanish
Mandarin Chinese 
        


That same week, The Lancet published not only the Appeal, but also an editorial and a commentary on the WOF:

Stop Cancer Now!

An appeal to world leaders: stop cancer now!
Franco Cavalli


On 16 December 2013, the three WOF-related papers were published:

Global cancer patterns: causes and prevention
Paolo Vineis, Christopher P. Wild

Rethinking the war on cancer
Douglas Hanahan

Cancer survival: global surveillance will stimulate health policy and improve equity
Michel P. Coleman